Laman UtamaBBN • SWX
add
Bellevue Group AG
Tutup sebelumnya
CHF 14.10
Julat hari
CHF 13.50 - CHF 14.15
Julat tahun
CHF 11.05 - CHF 24.30
Permodalan pasaran
181.73J CHF
Bilangan Purata
9.33K
Nisbah P/E
12.18
Hasil dividen
8.52%
Pertukaran utama
SWX
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(CHF) | Jun 2024info | Perubahan T/T |
---|---|---|
Hasil | 18.41J | -11.31% |
Perbelanjaan pengendalian | 13.73J | -10.56% |
Pendapatan bersih | 3.72J | -7.22% |
Margin untung bersih | 20.18 | 4.61% |
Pendapatan bagi setiap syer | — | — |
EBITDA | — | — |
Kadar cukai berkesan | 17.26% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
(CHF) | Jun 2024info | Perubahan T/T |
---|---|---|
Pelaburan tunai dan jangka pendek | 30.49J | 100.63% |
Jumlah aset | 138.75J | -4.69% |
Jumlah liabiliti | 22.05J | -24.81% |
Jumlah ekuiti | 116.70J | — |
Syer tertunggak | 13.20J | — |
Harga kepada buku | 1.60 | — |
Pulangan pada aset | 10.71% | — |
Pulangan pada modal | — | — |
Aliran Tunai
Perubahan bersih dalam tunai
(CHF) | Jun 2024info | Perubahan T/T |
---|---|---|
Pendapatan bersih | 3.72J | -7.22% |
Tunai daripada operasi | 3.65J | 137.31% |
Tunai daripada pelaburan | — | — |
Tunai daripada pembiayaan | -8.10J | 45.85% |
Perubahan bersih dalam tunai | -4.17J | 83.13% |
Aliran tunai bebas | — | — |
Perihal
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
CEO
Diasaskan
1993
Tapak web
Pekerja
88